{"id":3870,"date":"2025-10-31T14:43:58","date_gmt":"2025-10-31T13:43:58","guid":{"rendered":"https:\/\/reseau-amylose.org\/rechercheamylose\/?p=3870"},"modified":"2025-10-31T15:16:12","modified_gmt":"2025-10-31T14:16:12","slug":"etude-ag10-amylose","status":"publish","type":"post","link":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/","title":{"rendered":"\u00c9tude AG10 (ACT-EARLY) : pr\u00e9venir l\u2019amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine gr\u00e2ce \u00e0 l\u2019Acoramidis"},"content":{"rendered":"\t\t<div data-elementor-type=\"wp-post\" data-elementor-id=\"3870\" class=\"elementor elementor-3870\" data-elementor-post-type=\"post\">\n\t\t\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-03a4d6a elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"03a4d6a\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-1c3b05b\" data-id=\"1c3b05b\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-7a7cae4 elementor-widget elementor-widget-heading\" data-id=\"7a7cae4\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h1 class=\"elementor-heading-title elementor-size-default\">\u00c9tude AG10 (ACT-EARLY) : pr\u00e9venir l\u2019amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine gr\u00e2ce \u00e0 l\u2019Acoramidis<\/h1>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-0e40669 elementor-widget elementor-widget-heading\" data-id=\"0e40669\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Une \u00e9tude pour pr\u00e9venir la maladie avant son apparition<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-43cd4cf elementor-widget elementor-widget-text-editor\" data-id=\"43cd4cf\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"1132\" data-end=\"1412\">L\u2019<strong data-start=\"1134\" data-end=\"1148\">\u00e9tude AG10<\/strong>, aussi appel\u00e9e <strong data-start=\"1164\" data-end=\"1177\">ACT-EARLY<\/strong>, s\u2019adresse aux personnes porteuses d\u2019une mutation du g\u00e8ne <strong data-start=\"1236\" data-end=\"1243\">TTR<\/strong>.<br data-start=\"1244\" data-end=\"1247\" \/>Cette mutation peut, chez certaines personnes, provoquer une <strong data-start=\"1308\" data-end=\"1355\">amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine (ATTR)<\/strong> \u2014 une maladie rare pouvant toucher le c\u0153ur et les nerfs.<\/p><p data-start=\"1414\" data-end=\"1769\">Aujourd\u2019hui, les traitements existants permettent de <strong data-start=\"1467\" data-end=\"1508\">ralentir la progression de la maladie<\/strong>, mais <strong data-start=\"1515\" data-end=\"1558\">aucun ne pr\u00e9vient encore son apparition<\/strong>.<br data-start=\"1559\" data-end=\"1562\" \/>C\u2019est pr\u00e9cis\u00e9ment l\u2019objectif de cette \u00e9tude : <strong data-start=\"1608\" data-end=\"1657\">\u00e9valuer l\u2019efficacit\u00e9 du m\u00e9dicament Acoramidis<\/strong> pour emp\u00eacher la survenue de la maladie chez les personnes porteuses du g\u00e8ne, avant l\u2019apparition des sympt\u00f4mes.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-826f855 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"826f855\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-67b448a\" data-id=\"67b448a\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-49aff1a elementor-widget elementor-widget-heading\" data-id=\"49aff1a\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">Le m\u00e9dicament \u00e9tudi\u00e9 : l\u2019Acoramidis<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-b5eb500 elementor-widget elementor-widget-text-editor\" data-id=\"b5eb500\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"1816\" data-end=\"2279\">L\u2019<strong data-start=\"1818\" data-end=\"1832\">Acoramidis<\/strong> est un m\u00e9dicament qui a pour objet de stabiliser la prot\u00e9ine <strong data-start=\"1877\" data-end=\"1901\">transthyr\u00e9tine (TTR)<\/strong> afin d\u2019emp\u00eacher sa d\u00e9gradation et son accumulation dans les organes.<br data-start=\"1970\" data-end=\"1973\" \/>Il a d\u00e9j\u00e0 d\u00e9montr\u00e9 son efficacit\u00e9 chez des patients atteints d\u2019amylose cardiaque et est autoris\u00e9 aux \u00c9tats-Unis et par l\u2019Agence Europ\u00e9enne du M\u00e9dicament.<br data-start=\"2126\" data-end=\"2129\" \/>En France, il est actuellement <strong data-start=\"2160\" data-end=\"2216\">en cours d\u2019\u00e9valuation par la Haute Autorit\u00e9 de Sant\u00e9<\/strong> pour d\u00e9finir ses conditions d\u2019utilisation et de remboursement.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<section class=\"elementor-section elementor-top-section elementor-element elementor-element-9e96ef6 elementor-section-boxed elementor-section-height-default elementor-section-height-default\" data-id=\"9e96ef6\" data-element_type=\"section\">\n\t\t\t\t\t\t<div class=\"elementor-container elementor-column-gap-default\">\n\t\t\t\t\t<div class=\"elementor-column elementor-col-100 elementor-top-column elementor-element elementor-element-c7af298\" data-id=\"c7af298\" data-element_type=\"column\">\n\t\t\t<div class=\"elementor-widget-wrap elementor-element-populated\">\n\t\t\t\t\t\t<div class=\"elementor-element elementor-element-cd98f12 elementor-widget elementor-widget-heading\" data-id=\"cd98f12\" data-element_type=\"widget\" data-widget_type=\"heading.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t<h2 class=\"elementor-heading-title elementor-size-default\">D\u00e9roulement de l\u2019\u00e9tude<\/h2>\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-be54ad6 elementor-widget elementor-widget-text-editor\" data-id=\"be54ad6\" data-element_type=\"widget\" data-widget_type=\"text-editor.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<p data-start=\"2313\" data-end=\"2453\">L\u2019\u00e9tude se d\u00e9roule sur <strong data-start=\"2336\" data-end=\"2368\">plusieurs ann\u00e9es (5 \u00e0 7 ans)<\/strong>, avec un suivi m\u00e9dical r\u00e9gulier assur\u00e9 par les \u00e9quipes hospitali\u00e8res sp\u00e9cialis\u00e9es.<\/p><h3 data-start=\"2455\" data-end=\"2491\">1. V\u00e9rification de l\u2019\u00e9ligibilit\u00e9<\/h3><p data-start=\"2492\" data-end=\"2596\">Chaque participant passe un <strong data-start=\"2520\" data-end=\"2537\">bilan complet<\/strong> pour s\u2019assurer qu\u2019aucun signe de maladie n\u2019est pr\u00e9sent :<\/p><ul><li data-start=\"2599\" data-end=\"2657\">examen cardiaque (IRM, \u00e9chographie, scintigraphie, ECG),<\/li><li data-start=\"2599\" data-end=\"2657\">examen neurologique (\u00e9lectromyogramme, conduction nerveuse),<\/li><li data-start=\"2599\" data-end=\"2657\">tests sanguins et urinaires.<\/li><\/ul><h3 data-start=\"2755\" data-end=\"2776\">2. Tirage au sort<\/h3><p data-start=\"2777\" data-end=\"3043\">Les participants re\u00e7oivent <strong data-start=\"2804\" data-end=\"2825\">soit l\u2019Acoramidis<\/strong>, <strong data-start=\"2827\" data-end=\"2846\">soit un placebo<\/strong>.<br data-start=\"2847\" data-end=\"2850\" \/>Ni le patient ni le m\u00e9decin ne savent quel traitement est administr\u00e9 (\u00e9tude dite \u00ab en double aveugle \u00bb).<br data-start=\"2954\" data-end=\"2957\" \/>En cas d\u2019apparition de sympt\u00f4mes, le placebo est arr\u00eat\u00e9 et le vrai traitement propos\u00e9.<\/p><h3 data-start=\"3045\" data-end=\"3066\">3. Suivi r\u00e9gulier<\/h3><ul><li data-start=\"3069\" data-end=\"3114\"><strong data-start=\"3069\" data-end=\"3093\">Visite cardiologique<\/strong> : tous les 12 mois<\/li><li data-start=\"3069\" data-end=\"3114\"><strong data-start=\"3117\" data-end=\"3140\">Visite neurologique<\/strong> : tous les 6 mois<\/li><li data-start=\"3069\" data-end=\"3114\"><strong data-start=\"3163\" data-end=\"3188\">Visites t\u00e9l\u00e9phoniques<\/strong> : tous les 3 mois<\/li><\/ul><p data-start=\"3210\" data-end=\"3273\">Ce suivi permet de d\u00e9tecter pr\u00e9cocement tout signe d\u2019\u00e9volution.<\/p>\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t<div class=\"elementor-element elementor-element-7d0bbdd elementor-align-center elementor-widget elementor-widget-button\" data-id=\"7d0bbdd\" data-element_type=\"widget\" data-widget_type=\"button.default\">\n\t\t\t\t<div class=\"elementor-widget-container\">\n\t\t\t\t\t\t\t\t\t<div class=\"elementor-button-wrapper\">\n\t\t\t\t\t<a class=\"elementor-button elementor-button-link elementor-size-sm\" href=\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-act-early\/\" target=\"_blank\">\n\t\t\t\t\t\t<span class=\"elementor-button-content-wrapper\">\n\t\t\t\t\t\t\t\t\t<span class=\"elementor-button-text\">Pour en savoir plus sur l'\u00e9tude - CLIQUEZ ICI<\/span>\n\t\t\t\t\t<\/span>\n\t\t\t\t\t<\/a>\n\t\t\t\t<\/div>\n\t\t\t\t\t\t\t\t<\/div>\n\t\t\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t<\/div>\n\t\t<\/section>\n\t\t\t\t<\/div>\n\t\t","protected":false},"excerpt":{"rendered":"<p>\u00c9tude AG10 (ACT-EARLY) : pr\u00e9venir l\u2019amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine gr\u00e2ce \u00e0 l\u2019Acoramidis Une \u00e9tude pour pr\u00e9venir la maladie avant son apparition L\u2019\u00e9tude AG10, aussi appel\u00e9e ACT-EARLY, s\u2019adresse aux personnes porteuses d\u2019une mutation du g\u00e8ne TTR.Cette mutation peut, chez certaines personnes, provoquer une amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine (ATTR) \u2014 une maladie rare pouvant toucher le c\u0153ur [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-3870","post","type-post","status-publish","format-standard","hentry","category-non-classe"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>\u00c9tude AG10 (ACT-EARLY) : Acoramidis et ATTR<\/title>\n<meta name=\"description\" content=\"AG10 (ACT-EARLY), essai clinique international sur l&#039;efficacit\u00e9 de l&#039;Acoramidis sur l&#039;ATTR (amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine)\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"\u00c9tude AG10 (ACT-EARLY) : Acoramidis et ATTR\" \/>\n<meta property=\"og:description\" content=\"AG10 (ACT-EARLY), essai clinique international sur l&#039;efficacit\u00e9 de l&#039;Acoramidis sur l&#039;ATTR (amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine)\" \/>\n<meta property=\"og:url\" content=\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/\" \/>\n<meta property=\"og:site_name\" content=\"R\u00e9seau Amylose Recherche\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-31T13:43:58+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-31T14:16:12+00:00\" \/>\n<meta name=\"author\" content=\"clotilde\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"clotilde\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/\",\"url\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/\",\"name\":\"\u00c9tude AG10 (ACT-EARLY) : Acoramidis et ATTR\",\"isPartOf\":{\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#website\"},\"datePublished\":\"2025-10-31T13:43:58+00:00\",\"dateModified\":\"2025-10-31T14:16:12+00:00\",\"author\":{\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#\/schema\/person\/8051a9db0408f31b59e66b2cac32d79d\"},\"description\":\"AG10 (ACT-EARLY), essai clinique international sur l'efficacit\u00e9 de l'Acoramidis sur l'ATTR (amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine)\",\"breadcrumb\":{\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"\u00c9tude AG10 (ACT-EARLY) : pr\u00e9venir l\u2019amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine gr\u00e2ce \u00e0 l\u2019Acoramidis\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#website\",\"url\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/\",\"name\":\"R\u00e9seau Amylose Recherche\",\"description\":\"Centre de r\u00e9f\u00e9rence des amyloses cardiaques\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#\/schema\/person\/8051a9db0408f31b59e66b2cac32d79d\",\"name\":\"clotilde\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/3f641b4dd50c316d26405faeae0e8e51a740bc88d8b45a75e5562aa57653f388?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/3f641b4dd50c316d26405faeae0e8e51a740bc88d8b45a75e5562aa57653f388?s=96&d=mm&r=g\",\"caption\":\"clotilde\"},\"url\":\"https:\/\/reseau-amylose.org\/rechercheamylose\/author\/clotilde\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"\u00c9tude AG10 (ACT-EARLY) : Acoramidis et ATTR","description":"AG10 (ACT-EARLY), essai clinique international sur l'efficacit\u00e9 de l'Acoramidis sur l'ATTR (amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/","og_locale":"fr_FR","og_type":"article","og_title":"\u00c9tude AG10 (ACT-EARLY) : Acoramidis et ATTR","og_description":"AG10 (ACT-EARLY), essai clinique international sur l'efficacit\u00e9 de l'Acoramidis sur l'ATTR (amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine)","og_url":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/","og_site_name":"R\u00e9seau Amylose Recherche","article_published_time":"2025-10-31T13:43:58+00:00","article_modified_time":"2025-10-31T14:16:12+00:00","author":"clotilde","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"clotilde","Dur\u00e9e de lecture estim\u00e9e":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/","url":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/","name":"\u00c9tude AG10 (ACT-EARLY) : Acoramidis et ATTR","isPartOf":{"@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#website"},"datePublished":"2025-10-31T13:43:58+00:00","dateModified":"2025-10-31T14:16:12+00:00","author":{"@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#\/schema\/person\/8051a9db0408f31b59e66b2cac32d79d"},"description":"AG10 (ACT-EARLY), essai clinique international sur l'efficacit\u00e9 de l'Acoramidis sur l'ATTR (amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine)","breadcrumb":{"@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/etude-ag10-amylose\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/reseau-amylose.org\/rechercheamylose\/"},{"@type":"ListItem","position":2,"name":"\u00c9tude AG10 (ACT-EARLY) : pr\u00e9venir l\u2019amylose h\u00e9r\u00e9ditaire \u00e0 transthyr\u00e9tine gr\u00e2ce \u00e0 l\u2019Acoramidis"}]},{"@type":"WebSite","@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#website","url":"https:\/\/reseau-amylose.org\/rechercheamylose\/","name":"R\u00e9seau Amylose Recherche","description":"Centre de r\u00e9f\u00e9rence des amyloses cardiaques","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/reseau-amylose.org\/rechercheamylose\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#\/schema\/person\/8051a9db0408f31b59e66b2cac32d79d","name":"clotilde","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/reseau-amylose.org\/rechercheamylose\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/3f641b4dd50c316d26405faeae0e8e51a740bc88d8b45a75e5562aa57653f388?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/3f641b4dd50c316d26405faeae0e8e51a740bc88d8b45a75e5562aa57653f388?s=96&d=mm&r=g","caption":"clotilde"},"url":"https:\/\/reseau-amylose.org\/rechercheamylose\/author\/clotilde\/"}]}},"jetpack_featured_media_url":"","acf":[],"_links":{"self":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/posts\/3870","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/comments?post=3870"}],"version-history":[{"count":7,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/posts\/3870\/revisions"}],"predecessor-version":[{"id":3887,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/posts\/3870\/revisions\/3887"}],"wp:attachment":[{"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/media?parent=3870"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/categories?post=3870"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/reseau-amylose.org\/rechercheamylose\/wp-json\/wp\/v2\/tags?post=3870"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}